Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Form 8.3 - Ted Baker

10 May 2022 12:27

Form 8.3 - Ted Baker

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Jupiter Fund Management Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeTed Baker plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure9th May 2022
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p Ordinary
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:5,360,0002.90  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:5,360,0002.90  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:None
Details, including nature of the rights concerned and relevant percentages:None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
5p OrdSale50,0001.3425
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
NONE    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:10th May 2022
Contact name:Jon Watson
Telephone number:0203 817 1672

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
21st Jul 202012:13 pmRNSChange of Director
21st Jul 20207:00 amRNSAGM Trading Update
9th Jul 20205:19 pmRNSBoard Changes - Replacement
9th Jul 20204:44 pmRNSBoard Changes
7th Jul 20205:47 pmRNSHolding(s) in Company
3rd Jul 20202:00 pmRNSNotice regarding ARA and Notice of AGM
1st Jul 202010:38 amRNSAppointment of Chairman
30th Jun 20204:55 pmRNSTotal Voting Rights
30th Jun 20204:55 pmRNSCompletion of sale and leaseback of UBB
30th Jun 20207:00 amRNSHolding(s) in Company
29th Jun 20203:00 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSNotice of AGM
24th Jun 20205:26 pmRNSHolding(s) in Company
24th Jun 20203:16 pmRNSHolding(s) in Company
23rd Jun 20205:25 pmRNSHolding(s) in Company
23rd Jun 20205:23 pmRNSHolding(s) in Company
23rd Jun 20207:00 amRNSBoard Update
22nd Jun 20204:54 pmRNSHolding(s) in Company
22nd Jun 20201:01 pmRNSHolding(s) in Company
19th Jun 202011:25 amRNSHolding(s) in Company
19th Jun 20208:00 amRNSDirector/PDMR Shareholding
19th Jun 20208:00 amRNSTotal Voting Rights
19th Jun 20207:00 amRNSAdmission of New Shares
18th Jun 20202:08 pmRNSResults of General Meeting
18th Jun 20207:00 amRNSResults of Open Offer and Offer for Subscription
9th Jun 20204:36 pmRNSPrice Monitoring Extension
5th Jun 20205:36 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSPublication of Prospectus
1st Jun 20206:01 pmRNSResults of Placing and Firm Placing
1st Jun 20207:00 amRNSAppointment of Auditor
1st Jun 20207:00 amRNSProposed Firm Placing and Placing and Open Offer
1st Jun 20207:00 amRNSFinal Results
18th May 202012:03 pmRNSPrice Monitoring Extension
18th May 20208:30 amRNSCFO Appointment
13th May 20204:36 pmRNSPrice Monitoring Extension
5th May 20205:36 pmRNSBlock listing Interim Review
22nd Apr 20208:16 amRNSAppointment of Chairman
2nd Apr 20209:02 amRNSHolding(s) in Company
31st Mar 202012:03 pmRNSPrice Monitoring Extension
30th Mar 20207:59 amRNSDirectorate Change
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSSale and leaseback, loan facility, COVID-19 update
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
2nd Mar 202012:11 pmRNSTotal Voting Rights
26th Feb 202010:00 amRNSStrategic Update
19th Feb 20205:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.